|
|
Article: Centinel Spine Commences US Evaluation of its New STALIF C(TM) Stand Alone Cervical IBF Device.
- Article from:
- Business Wire
- Article date:
- October 28, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MINNEAPOLIS -- Centinel Spine, Inc. announced today that it has initiated US Alpha Site evaluation of the STALIF C[TM] NO PROFILE[TM] Stand Alone Cervical IBF Device for single level use in the treatment of cervical degenerative disc disease. The Company expects STALIF C[TM] to be available in early 2009, enabling spine surgeons to use the technology as an IBF device without supplementary fixation.
This evaluation is expected to take from one to two months and will determine when Centinel Spine will initiate the US sales launch of the STALIF C[TM] device in 2009. "The Alpha Site evaluation of the STALIF C[TM] is an important step of many steps needed for bringing ...